VFA
ALIM

Virtus Fund Advisers’s Alimera Sciences ALIM Stock Holding History

Virtus Fund Advisers’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-149
Closed -$13K – 2020
2014
Q2 		$13K Buy
+149
New +$13.2K ﹤0.01% 2678

Other funds holding ALIM

PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Virtus Fund Advisers's ALIM Position: Q3 2014 in Review

Virtus Fund Advisers sold out of Alimera Sciences (ALIM) in Q3 2014, closing a stake of 149 shares — an estimated $13K sold.

Virtus Fund Advisers first reported a position in ALIM in Q2 2014 and held it in 1 quarter. The position peaked at $13K in Q2 2014. 60 funds tracked by Wall St. Rank hold ALIM as of Q3 2014.

  • Virtus Fund Advisers reported no remaining Alimera Sciences position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 149 Alimera Sciences shares in Q3 2014, an estimated $13K.
  • Virtus Fund Advisers first reported a position in Alimera Sciences in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's Alimera Sciences position peaked at $13K in Q2 2014.
  • 60 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.